Skip to main content

Table 1 Effect of SIRT3 on autophagy in several diseases

From: Advances in SIRT3 involvement in regulating autophagy-related mechanisms

The experimental subject

Effect of SIRT3 on autophagy factors

References

6 weeks SD male rats (OA model)

Enhanced expression levels of SIRT3, increased the expression of LC3B, Beclin − 1.

[26]

A549 cells (DOX)

Enhanced expression levels of SIRT3, increased the expression of LC3 and decreased the expression of p62.

[27]

10 weeks C57BL/6 male rats

Knockdown of SIRT3 resulted in decreased expression levels of LC3-II and Beclin-1.

[28]

SD rat (OGD model)

Enhanced expression levels of SIRT3, increased the expression of LC3-II and Beclin-1.

[29]

SH-SY5Y cells (PD model)

Enhanced expression levels of SIRT3 increased the expression of LC3- II, and Beclin − 1.

[30]

129S1/SvlmJ mice

(cardiac hypertrophy model)

Knockdown of SIRT3 expression levels, decreased the LC3- II, and Beclin − 1 expression, and increased p62 expression.

[31]

SH-SY5Y cells (PD model)

Inhibition of SIRT3 expression levels increased p62 expression.

[32]

10 weeks C57BL/6 mice (IRI model)

Knockdown of SIRT3 resulted in decreased expression levels of LC3-II and Beclin-1.

[33]

HK-2 cells (HG)

Enhanced expression of SIRT3, increased the expression of LC3- II and Beclin − 1 and decreased the expression of p62.

[34]

  1. OA: Osteoarthritis; DOX: Doxorubicin; OGD: Oxygen glucose deprivation; PD: Parkinson’s disease; IRI: Renal ischemia-reperfusion; HG: High glucose